naltrexone and antipyrine

naltrexone has been researched along with antipyrine in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (44.44)18.2507
2000's3 (33.33)29.6817
2010's2 (22.22)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jolivette, LJ; Ward, KW1
Lombardo, F; Obach, RS; Waters, NJ1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Ferrari, A; Ferretti, C; Pini, LA; Sternieri, E; Trenti, T1
Blasberg, RG; Hiraga, S; Ito, K; Patlak, CS; Pettigrew, KD; Sawada, Y1
Blasberg, RG; Channing, M; Kawai, R; Newman, AH; Rice, KC; Sawada, Y1
Dixon, R; Frye, RF; Matzke, GR; Rabinovitz, M; Schade, R1
Hussar, DA1

Other Studies

9 other study(ies) available for naltrexone and antipyrine

ArticleYear
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
    Journal of pharmaceutical sciences, 2005, Volume: 94, Issue:7

    Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution

2005
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Effects of long-term treatment with naltrexone on hepatic enzyme activity.
    Drug metabolism and drug interactions, 1991, Volume: 9, Issue:2

    Topics: Administration, Oral; Adult; Alkaline Phosphatase; Antipyrine; Cannabis; Female; gamma-Glutamyltransferase; Half-Life; Humans; Liver; Male; Naltrexone; Substance-Related Disorders

1991
Cerebrovascular transport of [125I]quinuclidinyl benzilate, [3H]cyclofoxy, and [14C]iodoantipyrine.
    The American journal of physiology, 1990, Volume: 258, Issue:5 Pt 2

    Topics: Animals; Antipyrine; Biological Transport; Blood Proteins; Capillaries; Carbon Radioisotopes; Cerebrovascular Circulation; Diffusion; Erythrocytes; Indicator Dilution Techniques; Iodine Radioisotopes; Male; Models, Cardiovascular; Naltrexone; Permeability; Quinuclidines; Quinuclidinyl Benzilate; Rats; Time Factors; Tritium

1990
BBB transport and rapid tissue binding of cyclofoxy: comparison of active and inactive enantiomers.
    The American journal of physiology, 1990, Volume: 259, Issue:4 Pt 2

    Topics: Animals; Antipyrine; Binding, Competitive; Biological Transport; Blood-Brain Barrier; Cerebrovascular Circulation; Hydrogen-Ion Concentration; Kinetics; Lipid Metabolism; Male; Naltrexone; Rats; Rats, Inbred Strains; Stereoisomerism

1990
Effects of liver disease on the disposition of the opioid antagonist nalmefene.
    Clinical pharmacology and therapeutics, 1997, Volume: 61, Issue:1

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antipyrine; Case-Control Studies; Female; Galactose; Glucuronates; Humans; Injections, Intravenous; Liver Diseases; Male; Matched-Pair Analysis; Middle Aged; Naltrexone; Narcotic Antagonists; Severity of Illness Index

1997
New Drugs 2018, part 1.
    Nursing, 2018, Volume: 48, Issue:2

    Topics: Aminoisobutyric Acids; Antibodies, Monoclonal; Antibodies, Neutralizing; Antipyrine; Benzamides; Benzimidazoles; Broadly Neutralizing Antibodies; Carbamates; Cyclopropanes; Drug Approval; Drug Combinations; Edaravone; Heterocyclic Compounds, 4 or More Rings; Humans; Lactams, Macrocyclic; Leucine; Macrocyclic Compounds; Naltrexone; Natriuretic Peptides; Proline; Pyridines; Pyrrolidines; Quinoxalines; Sofosbuvir; Sulfonamides; United States; United States Food and Drug Administration

2018